BOD Australia Ltd - Record additional $1.43m binding purchase order to further strengthen FY2020 revenue
BOD Australia Ltd (ASX:BDA)

Record additional $1.43m binding purchase order to further strengthen FY2020 revenue

Published May 06, 2020

What happened?


What's happened?

Bod Australia Ltd (ASX: BDA, “Bod”) has received a binding purchase order from Health & Happiness Group Ltd (H&H Group, HKSE: 1112) valued at $1.43m.

What are the key highlights?

  1. The majority of the record order is for Bod’s premium CBD products, sold directly to the UK consumers under the CBII brand (www.cbii-cbd.com) and includes soft gel cap products and CBD oil products.
  2. As per the pre-existing partnership agreement, H&H Group undertake the marketing, sales and distribution processes of collaborative products, defraying Bod’s working capital.
  3. Bod’s FY2020 revenue growth has been underpinned by the uptake of its CBII products in the UK, the launch of hemp-based products into 2,000 Australian stores under the Swisse Wellness brand and increased demand for Bod’s non-CBD herbal based product range.

file

For further details, please refer to the announcement linked below.

CEO's summary

Jo Patterson CEO of BOD Australia Ltd has provided a statement.
Jo Patterson
Jo Patterson
CEO, BOD Australia Ltd

"A binding purchase order of this size clearly demonstrates Bod’s ability to deliver innovative consumer products that are aligned with the brand and consumer demand. Further, it continues the upward trajectory in the Company’s order pipeline that in turn will generate sales in both domestic and large international markets. As more and more consumers connect with our trusted brands, we expect future purchase orders will naturally increase in size and value. We are experiencing strong uptake of our products across all business divisions and have a number of exciting initiatives pending, which will propel sales and revenue higher in the near term.”

Download Announcement

View this announcement as well as our full profile on the company.

Comments

Share your thoughts about this announcement...

Similar articles
Bod continues to achieve strong revenue growth in FY2020
What's happened? Bod Australia Ltd (ASX: BDA, “Bod”) advises that it has achieved strong revenue growth in recent months...
3 years ago
Bod continues to achieve upward trajectory in medicinal cannabis prescriptions
What's happened? Bod Australia Ltd (ASX: BDA, “Bod”) has advised that it is continuing to experience significant uptake...
3 years ago
First medical cannabis prescriptions received from UK patients participating in Project Twenty21
What's happened? Bod Australia Ltd (ASX: BDA, “Bod”) has confirmed first prescriptions of the Company’s MediCabilis™ med...
3 years ago
Around the web
Why these ASX firms are shying away from the pot stock label – Part Two
Neurotech says due to often negative publicity around cannabis companies it tends not to promote it...
via stockhead.com.au
Clinical results for ancient therapy help ASX cannabis stocks weed out competition
Several ASX companies are undergoing rigorous clinical trials to gain regulatory approval for their...
via stockhead.com.au
Weed Week: Decriminalising cannabis could save Aussie tax payers billions every year
Penington Institute says pot-related law enforcement costs us $1.7 billion a year   Local cannabis...
via stockhead.com.au
Powered by  
  • Company
    BOD Australia Ltd
  • Website
  • Sector
    Distributors
  • Industry
    Distributors
  • Code
    ASX:BDA
  • Socials
View BOD Australia Ltd's Profile

How do I invest?

Considering investing in BOD Australia Ltd?
Here's how to get started.
Low Cost Brokerage ASX Cheapest ASX Trading Platform
  1. 1

    Create account

    Open an account with an online broker of your choice. If you do not have an existing broker, consider Mawson Graham's A$9.50 flat fee platform.

    Sign up now »
  2. 2

    Search for ASX:BDA

    On your online investment platform search for the stock ticker code ASX:BDA to bring up the company's shares.

  3. 3

    Buy shares

    Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.

Up